These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1024552)

  • 1. [Study of the microbiological activity in vitro of BB-K-8, a new aminoglycoside antibiotic].
    Ravagnan G; Rasura M; Piccolomini R
    Boll Soc Ital Biol Sper; 1976 Sep; 52(18):1440-6. PubMed ID: 1024552
    [No Abstract]   [Full Text] [Related]  

  • 2. [Amikacin: a new semisynthetic aminoside antibiotic derivative of kanamycin A. Action spectrum].
    Periti P; Lamanna A; Nicoletti I; Mazzei T; Polito P
    G Ital Chemioter; 1975; 22(1-2):75-86. PubMed ID: 1235358
    [No Abstract]   [Full Text] [Related]  

  • 3. [The antibacterial activity of amikacin in comparison with four other aminoglycoside antibiotics (proceedings)].
    Schassan HH
    Zentralbl Bakteriol Orig A; 1976 Aug; 235(1-3):320-8. PubMed ID: 983520
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro susceptibility of gram negative bacteria to amikacin and its comparison with three other aminoglycoside antibiotics.
    Daniel J; Thomas M; Shanmugam J
    Indian J Pathol Microbiol; 1985 Apr; 28(2):115-9. PubMed ID: 3835114
    [No Abstract]   [Full Text] [Related]  

  • 5. [Microbiological characteristics of kanendomycin].
    Blandino G; Mattina R; Speciale A; Toscano MA
    G Ital Chemioter; 1977; 24(1-2):7-10. PubMed ID: 615765
    [No Abstract]   [Full Text] [Related]  

  • 6. [Studies on the in vitro antibacterial activities of homemade amikacin on the common bacterial pathogens].
    Wang QN; Jiang YF; Du JZ; Luo MY; Liu YH; Xu ZM
    Yao Xue Xue Bao; 1982 May; 17(5):321-6. PubMed ID: 7180464
    [No Abstract]   [Full Text] [Related]  

  • 7. [Sensitivity of gram-negative germs to Amikacin].
    Redjeb SB; Ennaifer M; Bissardon O; Ben Salah N; Boujnah A
    Tunis Med; 1979; 57(2-3):103-6. PubMed ID: 553336
    [No Abstract]   [Full Text] [Related]  

  • 8. The susceptibility of recently isolates of gram-negative bacteria to amikacin and other aminoglycosides.
    Lexomboon U; Duangmani C; Srimunta C
    J Med Assoc Thai; 1979 Oct; 62(10):544-9. PubMed ID: 501262
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro amikacin sensitivity testing.
    Vaidya AK; Salvekar PM; Wagle NM; Merchant SM
    Indian Pediatr; 1986 Jun; 23(6):415-8. PubMed ID: 3744520
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro antibacterial activity of amikacin, a new aminoglycoside, against clinical bacterial isolates from children.
    Marks MI
    J Clin Pharmacol; 1975 Apr; 15(4 Pt 1):246-51. PubMed ID: 1127131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Aspects of antibacterial therapy using amikacin].
    Grassi GG; Bucci R; Ferrara A
    G Ital Chemioter; 1976; 23(1):47-54. PubMed ID: 1029696
    [No Abstract]   [Full Text] [Related]  

  • 12. Synthesis and antibacterial activities of 1-N [(S)-omega-amino-2-hydroxyalkyl] kanamycin A derivatives.
    Richardson K; Jevons S; Moore JW; Ross BC; Wright JR
    J Antibiot (Tokyo); 1977 Oct; 30(10):843-6. PubMed ID: 591447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies on amikacin (BB-K8), a new aminoglycoside antibiotic (author's transl)].
    Kawano M; Irimajiri K; Higuchi J; Uchiyama T; Tsubura E
    Jpn J Antibiot; 1974 Aug; 27(4):446-50. PubMed ID: 4436954
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro studies with UK-18,892, a new aminoglycoside antibiotic.
    Jevons S; Cheeseman HE; Brammer KW
    Antimicrob Agents Chemother; 1978 Sep; 14(3):277-80. PubMed ID: 708005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Possible errors in the interpretation of bacterial sensitivity to aminoglycoside antibiotics].
    García Hierro P; Ponte Miramontes MC; Soriano García F
    Rev Clin Esp; 1980 Oct; 159(2):87-90. PubMed ID: 7209044
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro evaluation of ceftazidime (GR 20263), amikacin and sisomicin, in a model simulating serum pharmacokinetics of therapeutic doses.
    Xerri L; Orsolini P; Broggio R
    Chemioterapia; 1984 Oct; 3(5):271-7. PubMed ID: 6398124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compiled data on aminoglycoside, foremost netilmicin susceptibility of bacterial strains.
    Juhlin I; Tunevall G
    Scand J Infect Dis Suppl; 1980; Suppl 23():39-44. PubMed ID: 6782657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combined effect of cefotaxime and aminoglycoside antibiotics on Pseudomonas strains and group D streptococci].
    Linda H; Patzer J
    Med Dosw Mikrobiol; 1984; 36(4):223-9. PubMed ID: 6100122
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical pharmacology of the most frequently used aminoglucosides: gentamycin, tobramycin and amikacin].
    Cuena Boy R; Azanza Perea JR; Echeverría Echepare LM; Honorato Pérez J
    Rev Med Univ Navarra; 1983 Dec; 27(4):21-7. PubMed ID: 6676898
    [No Abstract]   [Full Text] [Related]  

  • 20. [Sensitivity to kanendomycin in vitro of gram-negative bacterial strains].
    Carbone M; Focà A; Merendino R; De Rosa M
    G Ital Chemioter; 1977; 24(1-2):103-8. PubMed ID: 615751
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.